Day 3 - Thursday, November 20, 2025Thursday, 20 November 2025 - ET (Eastern Time, GMT-05:00)

As the healthcare landscape evolves with this landmark legislation, manufacturers must strategically adapt their patient support programs to ensure continued access. During this session, break down the critical implications of this bill, including key provisions and the critical implications on your copay and reimbursement strategies.

• Dissect the effect of cuts to Medicaid and Medicare and changes to ACA insurance enrollment on Copay and PAP program

• How will the site-neutral payment provisions for drug administration services impact your existing copay program design and patient affordability initiatives?

• What new transparency requirements should manufacturers anticipate, and how can you proactively restructure patient support programs to align with these changes?

• What are the key timeline considerations for implementation, and how should teams prepare for the phased approach beginning in 2025?

• Understand how patient access programs evolve over time, and in turn, may look different at launch vs mid life cycle vs end life cycle
• Pinpoint the KPIs and metrics to measure success at each stage, with an understanding that ROI cannot be the sole defining factor
• Discuss best practices to ensure that you are maintaining a robust patient access strategy throughout the programs entire lifecycle
• Identify the key measurables to look for in order to adjust and better align with brand strategy

With PBM revenue models shifting and legislative reform on the table, market access and copay teams must prepare for new contracting hurdles, formulary access restrictions and changing cost-sharing dynamics. As PBMs move away from rebates toward fee-based structures, manufacturers will see a ripple effect in copay design, accumulators/maximizers and patient affordability strategies.

• Learn how PBM strategies impact manufacturer copay programs and how to adjust for higher patient cost-sharing
• Understand formulary placement shifts and what to expect in payer negotiations.
• Legislative updates – will PBM reform materialize and how should manufacturers prepare?

During this session, uncover insights from patients directly into their lived experiences with health insurance, including how current benefit designs often fall short and how innovative approaches can better address patient need. Learn from real patient perspectives on affordability challenges, emotional impacts and preferred insurance design changes that can inform your organization's approach to copay and reimbursement strategies.